Stem Cell Research Leads To Potential New Therapy For Rare Blood DisorderA unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leukemia.TaiGen Initiates Phase I Trial Of The Stem Cell Mobilizer TG-0054TaiGen Biotechnology Co., Ltd. announced the enrollment for the TG-0054 phase I trial under an IND from the US FDA. TG-0054 is a potent and selective inhibitor for the binding of the chemokine cell-surface receptor CXCR4 to its ligand SDF-1 and efficiently mobilizes stem cells (CD34+) and endothelial progenitor cells (CD133+) from bone marrow into peripheral circulation in a mouse model. TG-0054 will initially be developed for the indication of stem cell transplantation in cancer patients.Mesoblast Limited (ASX:MSB) U.S. Heart Attack Stem Cell Therapy Trial UpdateDoctors at Houston's Texas Heart Institute held a press conference last Saturday (AEST) to provide an update on the ongoing multi-centre Phase 2 clinical trial of the proprietary mesenchymal precursor cell (MPC) technology in patients with heart attacks. This is the first trial in the world to evaluate an allogeneic, or "off-the-shelf", stem cell therapy injected directly into damaged heart muscle by cardiac catheter.U.K. Parliament To Consider Embryonic Stem Cell Research Legislation With Implications For Abortion LawThe House of Commons is set to consider legislation on human embryonic stem cell research, USA Today reports. The most controversial piece of the legislation would formalize parliamentary approval for the creation of human-animal hybrid embryos for stem cell research. Embryos would be prevented by law from developing past 14 days.Treating Parkinson's With Grafted Fetal Cells May Not Work In Long TermA new study by scientists in the US suggests that grafting fetal cells into a diseased brain as a way to treat Parkinson's may not be effective in the long term because the disease is an ongoing process that eventually affects the new cells. The finding raises questions about the long term value of stem cell therapy in the treatment of Parkinson's.Advanced Cell Technology Platform Yields Over 140 Cell Types From Human Embryonic Stem CellsAdvanced Cell Technology, Inc. (OTCBB: ACTC; http://www.advancedcell.com) reported on a large-scale differentiation process that has generated panels of differentiating human progenitor cell lines from human embryonic stem cells (hESCs). The research will be published in the April issue of Regenerative Medicine (Vol. 3[3] e-pub ahead of print) and will be freely available at
Chlamydia Std Statistics
Leg Fibromyalgia
Sleep Apnea Adenoids
Lack Of Sexual Drive
What Statistics Exist About Chlamydia
Two Uterus
Pain After Hysterectomy Treatment
Kansas Warrants Criminal
Baby Gap Hat Girl Clothing Shoes Accessories
Premature Baby Growth Chart
Working With Pregnant Teens
Bradley Method Natural Childbirth
Medical Information Websites Doctors
Bone Demineralization With Fibromyalgia
Does Penicillin Treat Chlamydia
No comments:
Post a Comment